Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV/AIDS. It was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.

Based on the paragraph above can we conclude that "Amdoxovir will end up as a treatment for things that don't involve HIV/AIDS. "?
It's impossible to say